
- This event has passed.
Spotlight on: Anti-Obesity drugs
7th November 2023 @ 5:30 pm - 6:30 pm
The popularity of weight loss drugs originally popularised within the United States have recently been approved for use by the National Institute for Health and Care Excellence (NICE). It concluded that semaglutide (Wegovy) exhibits efficacy as a viable treatment for weight loss management when integrated with dietary and lifestyle modifications.
Join this one-hour webinar, where experts in the field will:
- Explain how the drugs work, who should receive them and why the use of Wegovy is limited to 2 years
- Consider the risks of the drugs, their potential side effects and inappropriate use outside the criteria set out by NICE
- Imagine the future of obesity management and where drug treatment might play a role in the future
- This session will be valuable for those engaged in prescribing these treatments and seeking insights into the latest legislative updates and guidance.
